GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Revive Therapeutics Ltd (XCNQ:RVV) » Definitions » E10

Revive Therapeutics (XCNQ:RVV) E10 : C$-0.07 (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Revive Therapeutics E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Revive Therapeutics's adjusted earnings per share data for the three months ended in Dec. 2023 was C$-0.002. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is C$-0.07 for the trailing ten years ended in Dec. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-06-06), Revive Therapeutics's current stock price is C$0.02. Revive Therapeutics's E10 for the quarter that ended in Dec. 2023 was C$-0.07. Revive Therapeutics's Shiller PE Ratio of today is .


Revive Therapeutics E10 Historical Data

The historical data trend for Revive Therapeutics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revive Therapeutics E10 Chart

Revive Therapeutics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Revive Therapeutics Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -0.08 -0.07

Competitive Comparison of Revive Therapeutics's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Revive Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Revive Therapeutics's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Revive Therapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Revive Therapeutics's Shiller PE Ratio falls into.



Revive Therapeutics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Revive Therapeutics's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.002/125.0724*125.0724
=-0.002

Current CPI (Dec. 2023) = 125.0724.

Revive Therapeutics Quarterly Data

per share eps CPI Adj_EPS
201312 -0.031 96.945 -0.040
201403 -0.016 98.604 -0.020
201406 -0.016 99.473 -0.020
201409 -0.016 99.394 -0.020
201412 -0.016 98.367 -0.020
201503 -0.016 99.789 -0.020
201506 -0.035 100.500 -0.044
201509 -0.040 100.421 -0.050
201512 -0.030 99.947 -0.038
201603 -0.020 101.054 -0.025
201606 -0.020 102.002 -0.025
201609 -0.010 101.765 -0.012
201612 -0.010 101.449 -0.012
201703 -0.010 102.634 -0.012
201706 -0.010 103.029 -0.012
201709 -0.010 103.345 -0.012
201712 -0.010 103.345 -0.012
201803 -0.010 105.004 -0.012
201806 -0.010 105.557 -0.012
201809 -0.010 105.636 -0.012
201812 -0.010 105.399 -0.012
201903 -0.004 106.979 -0.005
201906 -0.010 107.690 -0.012
201909 -0.004 107.611 -0.005
201912 -0.010 107.769 -0.012
202003 -0.020 107.927 -0.023
202006 -0.015 108.401 -0.017
202009 -0.020 108.164 -0.023
202012 -0.010 108.559 -0.012
202103 -0.010 110.298 -0.011
202106 -0.030 111.720 -0.034
202109 -0.020 112.905 -0.022
202112 -0.010 113.774 -0.011
202203 -0.020 117.646 -0.021
202206 -0.010 120.806 -0.010
202209 -0.010 120.648 -0.010
202212 -0.005 120.964 -0.005
202306 0.000 124.203 0.000
202309 -0.001 125.230 -0.001
202312 -0.002 125.072 -0.002

Add all the adjusted EPS together and divide 10 will get our e10.


Revive Therapeutics  (XCNQ:RVV) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Revive Therapeutics E10 Related Terms

Thank you for viewing the detailed overview of Revive Therapeutics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Revive Therapeutics (XCNQ:RVV) Business Description

Traded in Other Exchanges
Address
82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
Revive Therapeutics Ltd is focused on the research, development, and commercialization of novel psychedelic and cannabinoid-based life sciences products and drug repurposing for infectious diseases. The firm's technology is being developed to fill the medical needs for diseases and disorders such as pain, inflammation, and wound care.
Executives
Michael Frank Director, Senior Officer

Revive Therapeutics (XCNQ:RVV) Headlines

No Headlines